Outcomes of Hematologic Malignancies after Unrelated Donor Hematopoietic Cell Transplantation According to Place of Residence

Biology of Blood and Marrow Transplantation

Volumn 16, Issue 3, 2010, Pages 368-375

  Loberiza Jr , Fausto R ^a   Lee, Stephanie J ^b   Klein, John P ^c   Hassebroek, Anna ^d   Dehn, Jason G ^d   Frangoul, Haydar A ^e   Hahn, Theresa ^f   Hale, Gregory ^g   Lazarus, Hillard M ^h   LeMaistre, Charles F ⁱ   Maziarz, Richard T ^j   Rizzo, J Douglas ^c   Majhail, Navneet S ^d,k  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b USA   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d NATIONAL MARROW DONOR PROGRAM   (United States)

^e VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^f ROSWELL PARK CANCER INSTITUTE   (United States)

^g A Children's Hospital   (United States)

^h UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

ⁱ TEXAS TRANSPLANT INSTITUTE   (United States)

^j OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^k UNIVERSITY OF MINNESOTA   (United States)

more..

Author keywords

Rural; Socioeconomic status; Unrelated donor hematopoietic cell transplantation

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER MORTALITY; CAUSE OF DEATH; CHILD; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DONOR; DONOR SELECTION; FEMALE; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; OUTCOME ASSESSMENT; PATIENT CARE; PRESCHOOL CHILD; RURAL AREA; SCHOOL CHILD; SOCIAL STATUS; URBAN AREA; URBAN RURAL DIFFERENCE;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CONTINENTAL POPULATION GROUPS; DISEASE-FREE SURVIVAL; FEMALE; GRAFT REJECTION; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCOME; INFANT; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; RURAL HEALTH; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; UNITED STATES; URBAN HEALTH; YOUNG ADULT;

EID: 75749146165     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2009.10.028     Document Type: Article

References (21)

1. Appelbaum F.R. The use of bone marrow and peripheral blood stem cell transplantation in the treatment of cancer. CA Cancer J Clin 46 (1996) 142-164
2. Bortin M.M., Horowitz M.M., and Rimm A.A. Increasing utilization of allogeneic bone marrow transplantation. Results of the 1988-1990 survey. Ann Intern Med 116 (1992) 505-512
3. Gratwohl A., Passweg J., Baldomero H., et al. Hematopoietic stem cell transplantation activity in Europe 1999. Bone Marrow Transplant 27 (2001) 899-916
4. Passweg J.R., Rowlings P.A., and Armitage J.O. Report from the International Bone Marrow Transplant Registry and Autologous Blood and Marrow Transplant Registry-North America. In: Cecka J.M., and Teraski P.I. (Eds). Clinical transplants (1996), UCLA Tissue Typing Laboratory, Los Angeles, CA 117-127
5. Eapen M. Report on state of the art in blood and marrow transplantation. Int Bone Marrow Transplant Registry/Autologous Blood Marrow Transplant Registry Newslett 9 (2002) 4-11
6. Edelman M.A., and Menz B.L. Selected comparison and implications of a national rural and urban survey on health care access, demographics, and policy issues. J Rural Health 12 (1996) 197-205
7. Goodman D.C., Fisher E., Stukel T.A., et al. The distance to community medical care and likelihood of hospitalization: is closer always better?. Am J Public Health 87 (1997) 1144-1150
8. Rao K., Darrington D., Schumacher J.J., et al. Disparity in survival outcome after hematopoietic stem cell transplantation for hematologic malignancies according to area of primary residence. Biol Blood Marrow Transplant 13 (2007) 1508-1514
9. Chan L., Hart L.G., and Goodman D.C. Geographic access to health care for rural Medicare beneficiaries. J Rural Health 22 (2006) 140-146
10. Martin-Mcdonald K., Rogers-Clark C., Hegney D., et al. Experiences of regional and rural people with cancer being treated with radiotherapy in a metropolitan center. Int J Nurse Pract 9 (2003) 176-182
11. Farag S.S., Bacigalupo A., Eapen M., et al. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry. Biol Blood Marrow Transplant 12 (2006) 876-884
12. Hart L.G., Larsen E.H., and Lishner D.M. Rural definitions for health policy and research. Am J Public Health 95 (2005) 1149-1155
13. Sinnott R. Virtues of the Haversine. Sky Telescope 68 (1984) 159
14. Zipcode.com. US Zip Code Database-deluxe database specifications. http://www.zip-code.com.
15. Weisdorf D., Spellman S., Haagenson M., et al. Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival. Biol Blood Marrow Transplant 14 (2008) 748-758
16. Aday L.A., and Anderson R. Development of Indices of Access to Medical Care (1975), Health Administration Press, Ann Arbor, MI
17. Shortell S. Continuity of medical care: conceptualization and measurement. Med Care 14 (1976) 377-391
18. Franzini L., Williams A.F., Franklin J., Singletary S.E., and Theriault R.L. Effects of race and socioeconomic status on survival of 1,332 black, Hispanic, and white women with breast cancer. Ann Surg Oncol 4 (1997) 111-118
19. Zell J.A., Cinar P., Mobasher M., Ziogas A., Meyskens Jr. F.L., and Anton-Culver H. Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment. J Clin Oncol 26 (2008) 66-75
20. Zell J.A., Rhee J.M., Ziogas A., Lipkin S.M., and Anton-Culver H. Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California. Cancer Epidemiol Biomarkers Prev 16 (2007) 546-552
21. Mackillop W.J., Zhang-Salomons J., Groome P.A., Paszat L., and Holowaty E. Socioeconomic status and cancer survival in Ontario. J Clin Oncol 15 (1997) 1680-1689